SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Investment analysts at National Bank Financial reduced their Q2 2025 EPS estimates for SNC-Lavalin Group in a research report issued to clients and investors on Thursday, March 13th. National Bank Financial analyst M. Sytchev now anticipates that the company will post earnings per share of $0.65 for the quarter, down from their prior forecast of $0.77. National Bank Financial also issued estimates for SNC-Lavalin Group’s Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.89 EPS and FY2026 earnings at $3.49 EPS.
Separately, Stifel Canada raised shares of SNC-Lavalin Group to a “strong-buy” rating in a research note on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
See Also
- Five stocks we like better than SNC-Lavalin Group
- What is Short Interest? How to Use It
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Short a Stock in 5 Easy Steps
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
